Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

May 17, 2025
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

1
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

2
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

3
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

4
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

5
September 22, 2023October 1, 2023

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

6

Search Field

Subscribe Now

  • Home
  • coronaremedies

Tag: coronaremedies

  • India

Indian Covaxin – One Step closer to success

bioxone September 18, 2020September 18, 2020 2

–Thota Kanishka Rao, Amity University Kolkata Hyderabad-based Bharat Biotech in a joint effort with analysts from the ICMR’s National Institute of Virology, based in Pune has delivered the information from the creature preliminaries of its immunization competitor. It demonstrated that Covaxin had the option to produce ‘robust immune responses. The two-portion vaccination routine of Covaxin […]

Read More
  • BiotechToday
  • World

COVID UPDATE: Newly discovered tiny antibodies are completely defeating the menacing coronavirus

bioxone September 16, 2020September 16, 2020

-Binayak Das,Team bioXone A team of scientists has successfully isolated what they believe to be, as being the smallest biological molecule found till date, it being approximately one-tenth the size of an average antibody molecule. They have designed a therapeutic and pre-emptive drug called- Ab8 using it, which they propose will be able to not […]

Read More
  • BiotechToday
  • FEATURED
  • India
  • Latest

Are you resistant after recovery from Covid-19?

bioxone September 15, 2020September 14, 2020 2

-Mayukh Sinha, Amity University Kolkata The COVID-19 pandemic is the trending matter of concern. In addition to that, the post-recovery health of COVID-19 patients has imposed a threat as well. It has been reported that a 33-year-old Chinese man caught his second infection. It simply posed a doubt on the human immune system’s ability to […]

Read More
  • BiotechToday
  • FEATURED
  • Latest
  • World

Can one viral infection block the other?

bioxone September 13, 2020September 13, 2020 1

–Purbieta Nandy, Amity University Kolkata The Covid-19 pandemic has placed new urgency on examining the mechanisms influencing the spread of the virus. With each passing day, new techniques combating SARS-CoV-2 are coming up; One of those mechanisms is Viral Interference-phenomenon in which infection with one virus promotes resistance to other viruses. During the 2009 pandemic […]

Read More

Breaking News

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Exogenous Klotho as a Cognition Booster in Aging Primates

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy